Tag Archives: Solution

PervasID to Present Solution for Tracking Medical Equipment and Surgical Instruments at Electronic and Biomedical Engineering Expo 2022

Company to exhibit and deliver presentation on solution which enhances decontamination, increases sterilisation processes, ensures mission-critical medical devices are available at the right place and time, for robust and efficient care saving billions of pounds across the NHS Cambridge, UK – Friday 24th June 2022 – PervasID, the company providing best-in-class battery-free Radio Frequency IDentification… Read More »

Rockley Photonics, a leading integrated silicon photonic solution provider, closes additional $65 million to accelerate growth

Oxford, UK and Pasadena, California, 29 January 2021 – Rockley Photonics, a leading integrated optics solutions provider, today announced that it has closed an additional $ 65m round of growth capital from both new private funds and follow-on existing investor Morningside Ventures. To date, Rockley has raised over $ 290m of financing to develop its… Read More »

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain Print this page ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults… Read More »

A Sticky Solution to a Hard Problem : Interview with Dr. Luiz Alavarez, CEO of Theradaptive

The development of biomaterials for orthopedic applications is a crowded space with several large and small companies designing innovative materials. One approach is the use of these materials to deliver therapeutic proteins that enhance healing. Theradaptive has developed a novel method to modify the proteins themselves so that they coat the surface of implants like… Read More »

FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension

FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Print this page DURHAM, N.C.–(BUSINESS WIRE)–Mar. 12, 2019– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients… Read More »